General Information of Disease (ID: DISF9I3O)

Disease Name Paralysis
Synonyms tetraplegia; bilateral diplegia
Disease Class 8B60: Motor neuron disease
Definition Paralysis of all four limbs.
Disease Hierarchy
DISH9EST: Palsy
DISF9I3O: Paralysis
ICD Code
ICD-11
ICD-11: 8B60
ICD-10
ICD-10: G12.2
Disease Identifiers
MONDO ID
MONDO_0001590
MESH ID
D011782
UMLS CUI
C0034372
MedGen ID
19617
HPO ID
HP:0002445
SNOMED CT ID
11538006

Drug-Interaction Atlas (DIA) of This Disease

Drug-Interaction Atlas (DIA)
This Disease is Treated as An Indication in 2 Discontinued Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
ORG-9273 DMW1FT0 Discontinued in Phase 2 Small molecular drug [1]
ANQ-9040 DMRQFIE Discontinued in Phase 1 NA [2]
------------------------------------------------------------------------------------
This Disease is Treated as An Indication in 1 Investigative Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
ORG-9453 DM5X2RV Investigative NA [3]
------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)
This Disease Is Related to 2 DTT Molecule(s)
Gene Name DTT ID Evidence Level Mode of Inheritance REF
SLC6A3 TTVBI8W Strong CausalMutation [4]
ALDH3A2 TTB6UM0 Definitive Altered Expression [5]
------------------------------------------------------------------------------------
This Disease Is Related to 7 DOT Molecule(s)
Gene Name DOT ID Evidence Level Mode of Inheritance REF
PMP22 OTXWYWCZ Strong Biomarker [6]
TBCD OTS4JKNQ Strong Biomarker [7]
CENPJ OTZCQZN5 Definitive Biomarker [8]
FXYD1 OTNKT6GP Definitive Biomarker [9]
LDB1 OT20EAPR Definitive Genetic Variation [10]
RANBP2 OTFG5CVF Definitive Genetic Variation [11]
RPE OT0XT3JU Definitive Biomarker [12]
------------------------------------------------------------------------------------
⏷ Show the Full List of 7 DOT(s)

References

1 Dose-response relation, neuromuscular blocking action, intubation conditions, and cardiovascular effects of Org 9273, a new neuromuscular blocking agent. Anesth Analg. 1991 Jun;72(6):811-6.
2 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800003547)
3 The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954.
4 Genetic mapping and exome sequencing identify variants associated with five novel diseases. PLoS One. 2012;7(1):e28936. doi: 10.1371/journal.pone.0028936. Epub 2012 Jan 17.
5 Adeno-associated virus vectors are able to restore fatty aldehyde dehydrogenase-deficiency. Implications for gene therapy in Sjogren-Larsson syndrome.Arch Dermatol Res. 2005 Jun;296(12):568-72. doi: 10.1007/s00403-005-0556-x. Epub 2005 Apr 15.
6 Hereditary neuropathy with liability to pressure palsies emerging during vincristine treatment.Neurology. 2002 Nov 12;59(9):1470-1. doi: 10.1212/01.wnl.0000032505.45389.94.
7 Biallelic Mutations in TBCD, Encoding the Tubulin Folding Cofactor D, Perturb Microtubule Dynamics and Cause Early-Onset Encephalopathy. Am J Hum Genet. 2016 Oct 6;99(4):962-973. doi: 10.1016/j.ajhg.2016.08.003. Epub 2016 Sep 22.
8 Positive airway pressure for sleep-disordered breathing in acute quadriplegia: a randomised controlled trial.Thorax. 2019 Mar;74(3):282-290. doi: 10.1136/thoraxjnl-2018-212319. Epub 2018 Dec 11.
9 Periodic limb movements in tetraplegia.J Spinal Cord Med. 2018 May;41(3):318-325. doi: 10.1080/10790268.2017.1320874. Epub 2017 May 2.
10 The graded redefined assessment of strength sensibility and prehension version 2 (GV2): Psychometric properties.J Spinal Cord Med. 2019 Oct;42(sup1):149-157. doi: 10.1080/10790268.2019.1616950.
11 Acute necrotizing encephalopathy (ANE1): rare autosomal-dominant disorder presenting as acute transverse myelitis.J Neurol. 2013 Jun;260(6):1545-53. doi: 10.1007/s00415-012-6825-7. Epub 2013 Jan 18.
12 Modeling Perceived Exertion during Graded Arm Cycling Exercise in Spinal Cord Injury.Med Sci Sports Exerc. 2017 Jun;49(6):1190-1196. doi: 10.1249/MSS.0000000000001203.